Literature DB >> 6614180

Carnitine transport in rat small intestine.

R D Shaw, B U Li, J W Hamilton, A L Shug, W A Olsen.   

Abstract

Although L-carnitine has been given orally to patients with systemic carnitine deficiency with successful control of the disease and is present in a variety of dietary sources, there is little available information on the physiology of its absorption. We therefore studied intestinal carnitine absorption in the rat by measuring the uptake of radioactive L-carnitine by everted intestinal rings and sacs. Active transport was demonstrated in duodenum and jejunum, but not ileum, with intracellular concentrations higher than medium concentrations at steady state and by the prevention of concentration gradients with anoxia, metabolic inhibitors, and replacement of sodium ion. Studies of the relationship of uptake to carnitine concentration demonstrated the presence of two components of transport: a saturable component (with a Km of between 206 and 316 microM) that could be inhibited by the metabolically inactive D-isomer and by acetylcarnitine and a linear component that we presume represents diffusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614180     DOI: 10.1152/ajpgi.1983.245.3.G376

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  In vitro drug absorption models. I. Brush border membrane vesicles, isolated mucosal cells and everted intestinal rings: characterization and salicylate accumulation.

Authors:  I Osiecka; P A Porter; R T Borchardt; J A Fix; C R Gardner
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

Review 2.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

Review 3.  Some pharmacokinetic considerations about homeostatic equilibrium of endogenous substances.

Authors:  A Marzo; A Rescigno; E Arrigoni Martelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

4.  Transport of carnitine into cells in hereditary carnitine deficiency.

Authors:  B O Eriksson; B Gustafson; S Lindstedt; I Nordin
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity.

Authors:  V Hack; O Stütz; R Kinscherf; M Schykowski; M Kellerer; E Holm; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

6.  Developmental maturation and segmental distribution of rat small intestinal L-carnitine uptake.

Authors:  P García-Miranda; J M Durán; M J Peral; A A Ilundáin
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

7.  Uptake of L-carnitine by rat jejunal brush border microvillous membrane vesicles. Evidence of passive diffusion.

Authors:  B U Li; P M Bummer; J W Hamilton; H Gudjonsson; G Zografi; W A Olsen
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

8.  In Vitro Drug Absorption Models. II. Salicylate, Cefoxitin, α-Methyldopa and Theophylline Uptake in Cells and Rings: Correlation with In Vivo Bioavailability.

Authors:  P A Porter; I Osiecka; R T Borchardt; J A Fix; L Frost; C Gardner
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

Review 9.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.